Chronic heart failure

There are 238 papers on chronic heart failure in aging research: 36 trials and 130 observational studies in people, 6 in animals, 55 reviews.

Disease

238 papers study it293 more mention it49 findings

39 new papers in 30 daysSee all 531 papers on chronic heart failure

At a glance

Chronic heart failure is linked with frailty and sarcopenia in human studies, slower gait in geriatric ward patients, and higher dementia risk. Human studies associate it with higher mortality after acute coronary syndrome discharge, but a study of critically ill COVID-19 patients shows no clear mortality link after adjustment for SOFA, age, sex and frailty.

49 findings in 36 papers from 2003 to 2026, 4 of them since May 2026

“Diabetes, stroke, HF and AF were significantly associated with dementia risk, hazard ratios ranged from 1.08 to 3.54.”
Association between cardiovascular diseases and dementia among various age groups: a population-based cohort study in older adultsScientific reports2023doi:10.1038/s41598-023-42071-8
  • Human trial36
  • Humans130
  • Animals6
  • In silico1

Interventions

2

Isoproterenol

upin rats1

1 study
  1. Isoproterenol induces chronic heart failure in rats.

    Animals10 mg/kg, four injections60 daysmales

More on Isoproterenol

NAD+

downin reviews1

1 study
  1. NAD+ decreases chronic heart failure (via mitochondrial redox state mechanism).

    Reviewvia mitochondrial redox state mechanismheart

More on NAD+

Effects

8

CC16

upin humans1

1 study
  1. Chronic heart failure is linked with higher CC16 in humans (adjusted linear regression) (est. = 4.69 (1.37; 8.02)).

    Humansadjusted linear regressionbetween 2011 and 2014n = 497

  2. Chronic heart failure is linked with higher CC16 in humans (est. 4.69 [1.37; 8.02], p = 5.91 × 10−3).

    Humans

More on CC16

Mortality

no changein humans1

1 study
  1. Chronic heart failure was not clearly linked with mortality in humans (critically ill COVID-19 patients after adjustment for SOFA, age, sex, and frailty) (aOR 1.2, 95% CI 0.5-1.5, P = 0.137).

    Humanscritically ill COVID-19 patients after adjustment for SOFA, age, sex, and frailtyn = 3,917

MIR21

upin humans1

1 study
  1. Chronic heart failure is linked with higher MIR21 in humans (chronic heart failure).

    Humanschronic heart failuremales

More on MIR21

Hand grip strength

downin humans1

1 study
  1. Chronic heart failure is linked with worse hand grip strength in patients with chronic heart failure compared to healthy controls.

    Humansin patients with chronic heart failure compared to healthy controlsmales

Hindlimb blood flow

downin rats1

1 study
  1. Chronic heart failure decreases hindlimb blood flow in rats during submaximal exercise (111±10 vs 133±12 mL/min/100g).

    Animalsduring submaximal exercisehindlimb muscle

Diaphragm blood flow

upin rats1

1 study
  1. Chronic heart failure increases diaphragm blood flow in rats during submaximal exercise (257±32 vs 121±9 mL/min/100g).

    Animalsduring submaximal exercisediaphragm

Inspiratory function

downin reviews1

1 study
  1. Chronic heart failure impairs inspiratory function (aging).

    Reviewagingdiaphragm

Daily physical activity level

downin humans1

1 study
  1. Chronic heart failure is linked with lower daily physical activity level in patients with CHF and patients with COPD.

    Humansin patients with CHF and patients with COPD

Upstream

1

Body mass index

no changein humans1HR 1.08

1 study
  1. Body mass index was not clearly linked with chronic heart failure in humans (adjusted for age, race, sex, site, education, smoking, COPD, and waist circumference) (HR 1.08, 95% CI 0.86-1.35).

    Humansadjusted for age, race, sex, site, education, smoking, COPD, and waist circumference6.1+/-1.4 yearsn = 2,435

More on Body mass index

Associations

27

Sarcopenia

upin humans5upin reviews1OR 6.1

6 studies
  1. Chronic heart failure is associated with sarcopenia in humans (Adjusted association) (Adjusted OR 6.1, 95% CI 2.70–13.73).

    HumansAdjusted associationn = 140

  2. Chronic heart failure is associated with sarcopenia in geriatric ward patients (40.4% vs. 29%, p = 0.046).

    Humansin geriatric ward patientsn = 416

  3. Chronic heart failure is associated with sarcopenia in humans (multivariable Cox regression) (PR 1.31, 95% CI 1.02-1.68).

    Humansmultivariable Cox regressionn = 588

  4. Sarcopenia is associated with chronic heart failure in patients with cardiovascular disease.

    Humansin patients with cardiovascular disease

  5. Chronic heart failure is associated with sarcopenia in CHF patients.

    Reviewin CHF patients

  6. Chronic heart failure is associated with sarcopenia.

    Review

More on Sarcopenia

Frailty

upin humans4

4 studies
  1. Chronic heart failure is linked with a higher risk of frailty in humans (multimorbidity) (β = 0.788).

    Humansmultimorbidityn = 3,836

  2. Chronic heart failure is associated with frailty in humans (compared with control patients, across six frailty tools) (30% to 52% vs. 2% to 15%).

    Humanscompared with control patients, across six frailty tools

  3. Chronic heart failure is associated with frailty in patients with chronic heart failure (39% (95% CI: 0.33-0.45)).

    Reviewin patients with chronic heart failuren = 6,287

  4. Chronic heart failure is associated with frailty in older patients with chronic heart failure (38% (95%CI: 0.32-0.44)).

    Reviewin older patients with chronic heart failuren = 4,797

Mortality

upin humans2OR 1.87

2 studies
  1. Chronic heart failure predicts mortality in humans after acute coronary syndrome discharge (sHR 1.99, 95% CI 1.96–2.02).

    Humansafter acute coronary syndrome discharge

  2. Chronic heart failure is linked with a higher risk of mortality in humans (critically ill COVID-19 patients in intensive care) (OR 1.87, 95% CI 1.5-2.3, P < 0.001).

    Humanscritically ill COVID-19 patients in intensive caren = 3,917

Senescence-related hub genes

mixedin humans1mixedin rats1

1 study
  1. senescence-related hub genes are associated with chronic heart failure in humans.

    Humans

  2. senescence-related hub genes are associated with chronic heart failure in rats (doxorubicin-induced CHF model).

    Animalsdoxorubicin-induced CHF model

Presence of at least one cardiovascular-renal-hepatic-metabolic syndrome component

upin humans1

1 study
  1. Chronic heart failure is associated with presence of at least one cardiovascular-renal-hepatic-metabolic syndrome component in humans (Hospitalized for chronic heart failure decompensation) (88.5% (n=370)).

    HumansHospitalized for chronic heart failure decompensationn = 418

Cognitive frailty

upin humans1

1 study
  1. Chronic heart failure is associated with cognitive frailty in humans (patients with chronic heart failure) (39.3% (95% CI: 31.0%-47.7%)).

    Reviewpatients with chronic heart failure

Inflammatory biomarkers

upin humans1

1 study
  1. Chronic heart failure is associated with inflammatory biomarkers in humans.

    Review

More on Inflammatory biomarkers

Corynebacterium

downin humans1

1 study
  1. Corynebacterium is linked with a lower risk of chronic heart failure in humans.

    Humans

More on Corynebacterium

Endothelial dysfunction

upin humans1

1 study
  1. Endothelial dysfunction raises the risk of chronic heart failure in CHF.

    Reviewin CHF

Senescence-related hub gene diagnostic model

upin silico1

1 study
  1. Senescence-related hub gene diagnostic model predicts chronic heart failure in silico (AUC exceeding 0.7).

    In silico

More on Senescence-related hub gene diagnostic model

All 27

Trial sponsors

Funding

13 grants since 2016

National Heart, Lung, and Blood Institute$7.1MJapan Society for the Promotion of Science¥25MJapan Society for the Promotion of Science

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 5Jan 2026: 30Feb 2026: 16Mar 2026: 14Apr 2026: 6May 2026: 6Jun 2026: 10Jul 2026: 11Aug 2026: 9Sep 2026: 8Oct 2026: 37Nov 2026: 10162 papers in 12 months

See all 531 papers on chronic heart failure